Traders purchased shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) on weakness during trading on Wednesday. $62.72 million flowed into the stock on the tick-up and $38.09 million flowed out of the stock on the tick-down, for a money net flow of $24.63 million into the stock. Of all equities tracked, Walgreens Boots Alliance had the 30th highest net in-flow for the day. Walgreens Boots Alliance traded down ($1.31) for the day and closed at $68.55
Several equities analysts recently issued reports on the company. BidaskClub raised Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research report on Wednesday, January 10th. Needham & Company LLC reaffirmed a “buy” rating and issued a $88.00 price objective (up from $86.00) on shares of Walgreens Boots Alliance in a research report on Wednesday, January 10th. Barclays assumed coverage on Walgreens Boots Alliance in a research report on Thursday, March 8th. They issued an “equal weight” rating and a $76.00 price objective on the stock. ValuEngine cut Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a research report on Friday, February 2nd. Finally, Vetr cut Walgreens Boots Alliance from a “strong-buy” rating to a “buy” rating in a research report on Friday, December 1st. One equities research analyst has rated the stock with a sell rating, eleven have assigned a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company. The company has an average rating of “Buy” and an average target price of $84.75.
The company has a market capitalization of $66,750.00, a P/E ratio of 18.61, a price-to-earnings-growth ratio of 1.15 and a beta of 1.21. The company has a current ratio of 0.96, a quick ratio of 0.47 and a debt-to-equity ratio of 0.48.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings data on Thursday, January 4th. The pharmacy operator reported $1.28 EPS for the quarter, topping the consensus estimate of $1.27 by $0.01. The firm had revenue of $30.74 billion during the quarter, compared to analyst estimates of $30.39 billion. Walgreens Boots Alliance had a return on equity of 19.15% and a net margin of 3.19%. Walgreens Boots Alliance’s revenue was up 7.9% on a year-over-year basis. During the same period in the prior year, the business posted $1.10 EPS. analysts predict that Walgreens Boots Alliance Inc will post 5.79 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which was paid on Monday, March 12th. Stockholders of record on Thursday, February 15th were paid a $0.40 dividend. The ex-dividend date of this dividend was Wednesday, February 14th. This represents a $1.60 annualized dividend and a dividend yield of 2.37%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is 44.20%.
In related news, insider Stefano Pessina acquired 98,858 shares of Walgreens Boots Alliance stock in a transaction dated Monday, January 15th. The stock was purchased at an average cost of $76.07 per share, for a total transaction of $7,520,128.06. The purchase was disclosed in a filing with the SEC, which is available through this link. Corporate insiders own 14.80% of the company’s stock.
Several large investors have recently bought and sold shares of the company. Westside Investment Management Inc. increased its stake in Walgreens Boots Alliance by 10.4% in the 2nd quarter. Westside Investment Management Inc. now owns 1,325 shares of the pharmacy operator’s stock worth $102,000 after buying an additional 125 shares in the last quarter. Zions Bancorporation increased its stake in Walgreens Boots Alliance by 983.3% in the 3rd quarter. Zions Bancorporation now owns 1,365 shares of the pharmacy operator’s stock worth $105,000 after buying an additional 1,239 shares in the last quarter. Financial Advocates Investment Management purchased a new stake in Walgreens Boots Alliance in the 4th quarter worth $125,000. Fieldpoint Private Securities LLC increased its stake in Walgreens Boots Alliance by 428.6% in the 4th quarter. Fieldpoint Private Securities LLC now owns 1,850 shares of the pharmacy operator’s stock worth $134,000 after buying an additional 1,500 shares in the last quarter. Finally, IHT Wealth Management LLC increased its stake in Walgreens Boots Alliance by 46.3% in the 2nd quarter. IHT Wealth Management LLC now owns 6,946 shares of the pharmacy operator’s stock worth $135,000 after buying an additional 2,199 shares in the last quarter. Hedge funds and other institutional investors own 61.00% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “Investors Buy Shares of Walgreens Boots Alliance (WBA) on Weakness” was reported by The Lincolnian Online and is owned by of The Lincolnian Online. If you are viewing this piece on another website, it was stolen and reposted in violation of US and international copyright laws. The correct version of this piece can be accessed at https://www.thelincolnianonline.com/2018/03/16/investors-buy-shares-of-walgreens-boots-alliance-wba-on-weakness.html.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.